Patient Engagement Solutions Market Size, Share | Research Report [2030]
The global Patient Engagement Solutions market gathered revenue around USD 16.9 billion in 2021 and market is set to grow USD 71.2 billion by the end of 2030 and is estimated to expand at a modest CAGR of 17.9% during the prediction period 2022 to 2030.
Growth Factors:
The key factors fueling the market growth include rising digitalization across healthcare, increasing prevalence of chronic conditions, and technological advancements. The COVID-19 pandemic boosted digitalization across healthcare. This, in turn, has fueled the awareness and adoption of patient engagement solutions, thus propelling the market growth.
As healthcare providers were battling with the constant upsurge in cases, patients were looking to digital technologies for care delivery and monitoring. This contributed to the market growth. Various key companies released multiple COVID-19-related features as part of their patient engagement lineup to enhance their offerings. In December 2020, athenahealth released new features to its athenaOne platform-such as scheduling, workflow, documentation, and reporting capabilities-to enable immediate administration of COVID-19 vaccines as and when they become available.
The necessity of social distancing resulted in the demand for remote patient monitoring solutions, along with the prerequisite for the precise and timely exchange of patient wellbeing records. The pandemic has also made healthcare professionals look for alternate methods to traditional processes and systems. As a result, market participants had come up with COVID-19-related features into their existing patient engagement solutions. For instance, in June 2020, Orion Health partnered with a network of more than 350 healthcare facilities called Keystone Health Information Exchange to enable real-time automated COVID-19 reporting for improved public health data collection across Pennsylvania and New Jersey.
As per a survey by Twilio, a provider of cloud communications and customer engagement, 68% of respondents reported accelerated digitalization in their organizations due to COVID-19. Companies reported easing of barriers at organization levels such as getting executive approvals, lack of clear strategy, and reluctance to replace legacy software. In fact, according to the Chief Product Officer at Mount Sinai Health System, their newly developed text?to?chat platform witnessed a 10x surge in volume due to the pandemic. The growing number of smartphone users around the globe expedited the adoption of digital health technologies across the sector both from providers and consumers, which, in turn, has augmented the dependability of patients on mHealth apps.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Patient Engagement Solutions market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Patient Engagement Solutions market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
| Report Scope | Details |
| Market Size | USD 71.2 billion by 2030 |
| Growth Rate | CAGR of 17.9% From 2022 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
| Segments Covered | Delivery type, component, functionality, therapeutic area, application, end user, region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | TCerner Corporation (Oracle); NextGen Healthcare, Inc.; Epic Systems Corporation; Allscripts Healthcare, LLC; McKesson Corporation; ResMed; Koninklijke Philips N.V.; Klara Technologies, Inc.; CPSI; Experian Information Solutions, Inc.; athenahealth, Inc.; Solutionreach, Inc.; IBM; MEDHOST; Nuance Communications, Inc.. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Patient Engagement Solutions market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional Insights
North America held the largest revenue share of over 35.2% in 2021 due to the presence of key players, increasing adoption of mhealth and EHR, and growing investment in patient engagement software by the major companies. Moreover, increasing awareness level, coupled with government spending on the healthcare sector, is expected to accelerate the growth. Europe held the second-largest share in 2021 owing to publicly funded systems such as the National Health Services (NHS) in the U.K. For instance, by 2020, the NHS planned to go completely paperless and provided patients access to EHRs since 2018.
The Asia Pacific market is expected to register a lucrative growth rate of 18.9% during the estimated period. The growing penetration of the internet and smartphone users, a large patient population, improving healthcare infrastructure and care quality, and the presence of local players are some of the key factors that are anticipated to offer lucrative growth opportunities to the market over the forecast period. Economic development in countries such as India and China is also supporting the growth of this region.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Patient Engagement Solutions Market include: Cerner Corporation (Oracle); NextGen Healthcare, Inc.; Epic Systems Corporation; Allscripts Healthcare, LLC; McKesson Corporation; ResMed; Koninklijke Philips N.V.; Klara Technologies, Inc.; CPSI; Experian Information Solutions, Inc.; athenahealth, Inc.; Solutionreach, Inc.; IBM; MEDHOST; Nuance Communications, Inc.
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Patient Engagement Solutions market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Patient Engagement Solutions market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Patient Engagement Solutions markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Patient Engagement Solutions Market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Patient Engagement Solutions Market, By Delivery Type
7.1. Patient Engagement Solutions Market, by Delivery Type, 2021-2030
7.1.1. Web & Cloud-based
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. On-premise
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Patient Engagement Solutions Market, By Application
8.1. Patient Engagement Solutions Market, by Application, 2021-2030
8.1.1. Software & Hardware
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Patient Engagement Solutions Market, By Functionality
9.1. Patient Engagement Solutions Market, by Functionality, 2021-2030
9.1.1. Communication
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Health Tracking & Insights
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Billing & Payments
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Administrative
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Patient Education
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Patient Engagement Solutions Market, By Therapeutic Area
10.1. Patient Engagement Solutions Market, by Therapeutic Area, 2021-2030
10.1.1. Health & Wellness
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Chronic Disease Management
10.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Patient Engagement Solutions Market, By Application
11.1. Patient Engagement Solutions Market, by Application, 2021-2030
11.1.1. Population Health Management
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Outpatient Health Management
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. In-patient Health Management
11.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Patient Engagement Solutions Market, By End-user
12.1. Patient Engagement Solutions Market, by End-user, 2021-2030
12.1.1. Payers
12.1.1.1. Market Revenue and Forecast (2019-2030)
12.1.2. Providers
12.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 13. Global Patient Engagement Solutions Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.6. Market Revenue and Forecast, by End-user (2019-2030)
13.1.7. U.S.
13.1.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.7. UK
13.2.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.8. Germany
13.2.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.9. France
13.2.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.10. Rest of Europe
13.2.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.7. India
13.3.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.9. Japan
13.3.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.10. Rest of APAC
13.3.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.7. GCC
13.4.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.9. South Africa
13.4.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.10. Rest of MEA
13.4.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5.7. Brazil
13.5.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.8.6. Market Revenue and Forecast, by End-user (2019-2030)
Chapter 14. Company Profiles
14.1. Cerner Corporation (Oracle)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. NextGen Healthcare, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Epic Systems Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Allscripts Healthcare, LLC
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. McKesson Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. ResMed
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Koninklijke Philips N.V.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Klara Technologies, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. CPSI
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Experian Information Solutions, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers